glp-1 obesity drug market forecast 2030 GLP-1 Obesity Home Delivery Injectables
Description
As a general trend from these comparisons, adherence to GLP-1 RAs seems to be better with lower injection frequencies
A critical consideration is that diabetes itself substantially increases gastroparesis riskaffecting up to 5% of patients with type 1 diabetes and 1% with type 2 diabetes
ACG Clinical Guideline: Gastroparesis
Cardio vs
doi: 10.1172/jci78371
The Foundations Have Not Changed None of this diminishes the importance of the strategies I discussed in the previous article
